ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...

Fast forward to January’s transfer deadline day and thanks to one Rangers coach the named Couhaib Driouech is once again on ...

Modern Healthcare: Philips Recalls Remote Cardiac Monitoring Software After 2 Deaths ... a summary of health policy coverage from major news organizations. Sign up for an email subscription.

says that dating clients is the only negative she can recall of her two decades in the ... The stories of creators such as Bonnie Blue and Lily Philips have gained traction after both competed ...

The deal is expected to close later this year, the companies said Tuesday. Related: Philips recalls remote cardiac monitoring software after 2 deaths The emergency care business, part of Philips ...

This is not the only recall the company is dealing with. Philips’ Respironics business has been facing issues with some of its sleep apnea products since June 2021 when it issued a recall of 15 ...

The Class I recall, the FDA’s severest classification, is a correction and does not require removing devices from where they are used or sold. Philips started the recall on Nov. 20, 2024 ...

The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect cases of hidden, transient arrhythmias that may only last minutes at a time.

Philips is recalling the software associated with its mobile cardiac outpatient telemetry devices after 109 patient injuries and two patient deaths, a Jan. 13 FDA recall notice said. The software ...